{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T09:33:05Z","timestamp":1786699985703,"version":"build-2736575974"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Reprod. Health"],"abstract":"<jats:p>Ovarian aging is a complex biological process traditionally attributed to the progressive depletion of the follicular reserve. However, accumulating evidence suggests that age-related reproductive decline is not solely determined by follicular loss but also by profound alterations in the ovarian microenvironment, including stromal fibrosis, vascular dysfunction, chronic low-grade inflammation, oxidative stress, and impaired intercellular communication. This evolving understanding has promoted a shift from a follicle-centered view of ovarian aging toward a broader ovarian niche\u2013centered paradigm. Within this context, platelet-rich plasma (PRP) has emerged as one of the most extensively investigated regenerative approaches in reproductive medicine. PRP provides a concentrated source of growth factors, cytokines, and bioactive mediators capable of modulating angiogenesis, tissue remodeling, inflammation, and cellular signaling. Nevertheless, interpretation of the available clinical evidence remains challenging due to substantial heterogeneity in PRP preparation protocols, biological composition, patient selection, and outcome measures. This narrative review examines the biological basis of PRP, its potential effects on the ovarian niche, and the current clinical evidence supporting its use in women with diminished ovarian reserve, poor ovarian response, premature ovarian insufficiency, and advanced reproductive age. Particular attention is given to the emerging concept that restoration of ovarian niche functionality, rather than isolated activation of residual follicles, may represent the primary biological objective of contemporary ovarian rejuvenation strategies. The review also explores the rationale for combining local regenerative interventions with systemic regenerative approaches, including hematopoietic progenitor cell mobilization induced by granulocyte colony-stimulating factor (G-CSF). We discuss the hypothesis that mobilization-induced changes in circulating progenitor cells, chemotactic signaling pathways, and the systemic regenerative milieu may enhance the biological activity of autologous regenerative products and contribute to ovarian niche restoration. Current evidence does not yet support definitive conclusions regarding the efficacy of ovarian rejuvenation therapies. However, the integration of local and systemic regenerative signals represents a promising avenue for future investigation. Further progress will require standardized biological products, robust biomarkers, and well-designed clinical trials capable of clarifying the mechanisms, indications, and clinical value of regenerative interventions targeting the ovarian niche.<\/jats:p>","DOI":"10.3389\/frph.2026.1921016","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T08:53:30Z","timestamp":1786697610000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Platelet-rich plasma in reproductive medicine: from ovarian follicles to the ovarian niche and emerging stem cell mobilization\u2013based regenerative strategies"],"prefix":"10.3389","volume":"8","author":[{"given":"Manuel","family":"Mu\u00f1oz-Cantero","sequence":"first","affiliation":[{"name":"IVI RMA Global, IVI Alicante","place":["Alicante, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amparo","family":"Santamar\u00eda Ortiz","sequence":"additional","affiliation":[{"name":"IVI RMA Global, IVI Alicante","place":["Alicante, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.fertnstert.2016.01.013","article-title":"Aging and the environment affect gamete and embryo potential: can we intervene?","volume":"105","author":"Meldrum","year":"2016","journal-title":"Fertil Steril"},{"key":"B2","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13048-023-01300-4","article-title":"The stromal microenvironment and ovarian aging: mechanisms and therapeutic opportunities","volume":"16","author":"Shen","year":"2023","journal-title":"J Ovarian Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e70481","DOI":"10.1002\/mco2.70481","article-title":"Ovarian aging: mechanisms, age-related disorders, and therapeutic interventions","volume":"6","author":"Liu","year":"2025","journal-title":"MedComm"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1113684","DOI":"10.3389\/fphys.2023.1113684","article-title":"Mechanisms of primordial follicle activation and new pregnancy opportunity for premature ovarian failure patients","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Physiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1210\/clinem\/dgac039","article-title":"Evaluation of female fertility\u2014AMH and ovarian reserve testing","volume":"107","author":"Cedars","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jama.2021.4788","article-title":"Diagnosis and management of infertility: a review","volume":"326","author":"Carson","year":"2021","journal-title":"JAMA"},{"key":"B7","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.rbmo.2022.12.011","article-title":"Ovarian rescue in women with premature ovarian insufficiency: facts and fiction","volume":"46","author":"Pellicer","year":"2023","journal-title":"Reprod Biomed Online"},{"key":"B8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1089\/ten.teb.2020.0205","article-title":"Adult stem cell therapy for premature ovarian failure: from bench to bedside","volume":"28","author":"Wang","year":"2022","journal-title":"Tissue Eng Part B Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"997808","DOI":"10.3389\/fimmu.2022.997808","article-title":"Bone marrow mesenchymal stem cells in premature ovarian failure: mechanisms and prospects","volume":"13","author":"Huang","year":"2022","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00404-023-07062-0","article-title":"Stem cell therapy for premature ovarian insufficiency: a systematic review and meta-analysis of animal and clinical studies","volume":"309","author":"Hu","year":"2024","journal-title":"Arch Gynecol Obstet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s10815-021-02146-9","article-title":"A narrative review of platelet-rich plasma (PRP) in reproductive medicine","volume":"38","author":"Sharara","year":"2021","journal-title":"J Assist Reprod Genet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"5284","DOI":"10.3390\/ijerph19095284","article-title":"Platelet rich plasma in gynecology\u2014discovering undiscovered","volume":"19","author":"Streit-Cie\u0107kiewicz","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B13","doi-asserted-by":"publisher","first-page":"103813","DOI":"10.1016\/j.rbmo.2024.103813","article-title":"Revitalizing female fertility: platelet-rich plasma\u2013hype or hope?","volume":"49","author":"Serdarogullari","year":"2024","journal-title":"Reprod Biomed Online"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1093\/humrep\/dez190","article-title":"Platelet-rich plasma another add-on treatment getting out of hand? How can clinicians preserve the best interest of their patients?","volume":"34","author":"Urman","year":"2019","journal-title":"Hum Reprod"},{"key":"B15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/GCO.0000000000000944","article-title":"Not all platelet-rich plasma are created equal","volume":"36","author":"Cantero","year":"2024","journal-title":"Curr Opin Obstet Gynecol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12884-024-06251-2","article-title":"The value of intraovarian autologous platelet rich plasma in women with poor ovarian reserve or ovarian insufficiency: a systematic review and meta-analysis","volume":"24","author":"Maged","year":"2024","journal-title":"BMC Pregnancy Childbirth"},{"key":"B17","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.fertnstert.2018.04.025","article-title":"Autologous stem cell ovarian transplantation to increase reproductive potential in patients who are poor responders","volume":"110","author":"Herraiz","year":"2018","journal-title":"Fertil Steril"},{"key":"B18","doi-asserted-by":"publisher","first-page":"65. e1","DOI":"10.1016\/j.ajog.2021.01.023","article-title":"Stem cell\u2013secreted factor therapy regenerates the ovarian niche and rescues follicles","volume":"225","author":"Buigues","year":"2021","journal-title":"Obstet Gynecol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.18632\/aging.206274","article-title":"Enhancing oocyte activation in women with ovarian failure: clinical outcomes of the stem cell regenera study using G-CSF mobilization of peripheral blood stem cells and intraovarian injection of stem cell factor-enriched platelet rich plasma in real-world-practice","volume":"17","author":"Santamaria","year":"2025","journal-title":"Aging (Albany NY)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10815-018-1386-z","article-title":"Platelet-rich plasma or blood-derived products to improve endometrial receptivity?","volume":"36","author":"Bos-Mikich","year":"2019","journal-title":"J Assist Reprod Genet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.3390\/jcm9061809","article-title":"Reactivating ovarian function through autologous platelet-rich plasma intraovarian infusion: pilot data on premature ovarian insufficiency, perimenopausal, menopausal, and poor responder women","volume":"9","author":"Sfakianoudis","year":"2020","journal-title":"J Clin Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"10211","DOI":"10.18632\/aging.103403","article-title":"Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency","volume":"12","author":"Cakiroglu","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1007\/s43032-021-00483-9","article-title":"Effects of intraovarian injection of autologous platelet-rich plasma on ovarian rejuvenation in poor responders and women with primary ovarian insufficiency","volume":"28","author":"Aflatoonian","year":"2021","journal-title":"Reprod Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/humrep\/deae038","article-title":"Intraovarian platelet-rich plasma injection and IVF outcomes in patients with poor ovarian response: a double-blind randomized controlled trial","volume":"39","author":"Barrenetxea","year":"2024","journal-title":"Hum Reprod"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1093\/humrep\/deae093","article-title":"Effect of intraovarian platelet-rich plasma injection on IVF outcomes in women with poor ovarian response: the PROVA randomized controlled trial","volume":"39","author":"Herlihy","year":"2024","journal-title":"Hum Reprod"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1182\/blood-2005-04-1417","article-title":"How do stem cells find their way home?","volume":"106","author":"Lapidot","year":"2005","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.it.2007.05.007","article-title":"The SDF-1\u2013CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis","volume":"28","author":"Petit","year":"2007","journal-title":"Trends Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13048-023-01151-z","article-title":"Mechanisms of ovarian aging in women: a review","volume":"16","author":"Wang","year":"2023","journal-title":"J Ovarian Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"561.e1","DOI":"10.1016\/j.ajog.2023.01.018","article-title":"Single intraovarian dose of stem cell\u2013and platelet-secreted factors mitigates age-related ovarian infertility in a murine model","volume":"228","author":"Marchante","year":"2023","journal-title":"Obstet Gynecol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13287-022-02724-3","article-title":"Mesenchymal stem cells combined with autocrosslinked hyaluronic acid improve mouse ovarian function by activating the PI3K-AKT pathway in a paracrine manner","volume":"13","author":"Jiao","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"B31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.fertnstert.2014.11.015","article-title":"Oocyte environment: follicular fluid and cumulus cells are critical for oocyte health","volume":"103","author":"Dumesic","year":"2015","journal-title":"Fertil Steril"},{"key":"B32","article-title":"Bone marrow derived stem cells restore ovarian function and fertility in premature ovarian insufficiency women. Interim report of a randomized trial: mobilization versus ovarian injection","author":"Pellicer De Castellv","year":"2020","journal-title":"Human Reproduction"},{"key":"B33","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1634\/stemcells.2004-0342","article-title":"Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1\u2013CXCR4 axis","volume":"23","author":"Kucia","year":"2005","journal-title":"Stem Cells"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1007\/s10815-025-03599-y","article-title":"Cellular therapies in primary ovarian insufficiency and poor ovarian reserve: a systematic review","volume":"42","author":"Seyihoglu","year":"2025","journal-title":"J Assist Reprod Genet"},{"key":"B35","doi-asserted-by":"publisher","first-page":"CD013875","DOI":"10.1002\/14651858.CD013875.pub2","article-title":"Autologous platelet-rich plasma for assisted reproduction","volume":"2024","author":"Vaidakis","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"B36","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s00404-026-08338-x","article-title":"Unlocking ovarian rejuvenation with platelet-rich plasma: systematic review and proposed clinical framework for controlled use in poor prognosis patients undergoing in vitro fertilisation","volume":"313","author":"Alageel","year":"2026","journal-title":"Arch Gynecol Obstet"},{"key":"B37","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/humupd\/dmt037","article-title":"Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice","volume":"20","author":"La Marca","year":"2014","journal-title":"Hum Reprod Update"},{"key":"B38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s43043-021-00077-0","article-title":"Intraovarian platelet-rich plasma: current status","volume":"26","author":"Elnashar","year":"2021","journal-title":"Middle East Fertil Soc J"},{"key":"B39","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/jcb.21043","article-title":"Cytokines and hematopoietic stem cell mobilization","volume":"99","author":"Nervi","year":"2006","journal-title":"J Cell Biochem"},{"key":"B40","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.fertnstert.2021.04.009","article-title":"Pathways and factors regulated by bone marrow-derived stem cells in human ovarian tissue","volume":"116","author":"Buigues","year":"2021","journal-title":"Fertil Steril"},{"key":"B41","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/bmt.2014.278","article-title":"A review of the genetic and long-term effects of G-CSF injections in healthy donors: a reassuring lack of evidence for the development of haematological malignancies","volume":"50","author":"Shaw","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"B42","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3324\/haematol.12285","article-title":"Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish donor registry","volume":"93","author":"de La Rubia","year":"2008","journal-title":"Haematologica"},{"key":"B43","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1517\/14712598.2012.674937","article-title":"Long-term safety of granulocyte colony-stimulating factor in normal donors: is it all clear?","volume":"12","author":"Martino","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"B44","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1126\/science.aax6184","article-title":"Downgrading of regulation in regenerative medicine","volume":"365","author":"Sipp","year":"2019","journal-title":"Science"}],"container-title":["Frontiers in Reproductive Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2026.1921016\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T08:53:31Z","timestamp":1786697611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2026.1921016\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":44,"alternative-id":["10.3389\/frph.2026.1921016"],"URL":"https:\/\/doi.org\/10.3389\/frph.2026.1921016","relation":{},"ISSN":["2673-3153"],"issn-type":[{"value":"2673-3153","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"article-number":"1921016"}}